FRETS-25-STD2

<strong>FRETS-25-STD2</strong> <strong>Catalog number:</strong> MDP0317 <strong>CAS Number: </strong>77739-21-0 <strong>Sequence: </strong>Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-ArgLys(Dnp):Nε-(2,4-Dinitrophenyl)lysine <strong>Amount:</strong> 1 mg <strong>Molecular Weight:</strong> 940 g/mol <strong>Supplied as:</strong> Powder <strong>Applications:</strong> molecular tool for various biochemical applications <strong>Storage:</strong> -20 °C <strong>WARNING:</strong> For in vitro Research Use Only. NOT for use on humans or animals. <strong>Grade:</strong> Biotechnology grade. All products are highly pure. <strong>References:</strong> 1: Mancini I, Valsecchi C, Lotta LA, Deforche L, Pontiggia S, Bajetta M, Palla R, Vanhoorelbeke K, Peyvandi F. FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients Thromb Haemost. 2014 Aug;112(2):297-303. 2: Frankel RM. Pets, vets, and frets: what relationship-centered care research has to offer veterinary medicine J Vet Med Educ. 2006 Spring;33(1):20-7. 3: Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay Br J Haematol. 2005 Apr;129(1):93-100. 4: Groot E, Hulstein JJ, Rison CN, de Groot PG, Fijnheer R. FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura J Thromb Haemost. 2006 Mar;4(3):698-9. 5: Wildenthal JA, Atkinson A, Lewis S, Sayood S, Nolan NS, Cabrera NL, Marschall J, Durkin MJ, Marks LR. Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs Clin Infect Dis. 2023 Feb 8;76(3):487-496. 6: Aslam B, Khurshid M, Nisar MA, Muzammil S, Hayat S. Superantigens: procession of frets Braz J Infect Dis. 2017 May-Jun;21(3):357-358. 7: Oda K, Takahashi T, Takada K, Tsunemi M, Ng KK, Hiraga K, Harada S. Exploring the subsite-structure of vimelysin and thermolysin using FRETS-libraries FEBS Lett. 2005 Sep 12;579(22):5013-8. 8: Kremer Hovinga JA, Mottini M, Lämmle B. Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: comparison with other assay methods J Thromb Haemost. 2006 May;4(5):1146-8. 9: Meyer SC, Sulzer I, Lämmle B, Kremer Hovinga JA. Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies J Thromb Haemost. 2007 Apr;5(4):866-7. <a href="https://pubmed.ncbi.nlm.nih.gov/17567447">10: Eckmann CM, De Laaf RT, Van Keulen JM, Van Mourik JA, De Laat B. Bilirubin oxidase as a solution for the interference of hyperbilirubinemia with ADAMTS-13 activity measurement by FRETS-VWF73 assay J Thromb Haemost. 2007 Jun;5(6):1330-1. </a> <br><strong>Products Related to FRETS-25-STD2 can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>